This is the class action lawsuit that I was referring to regarding the class-action lawsuit filed against both Abbott and Hospira: THE FACT SPEAK FOR THEMSELVES:
Verdict for Hospira in ERISA Class-Action Lawsuit
U.S. District Court for the Northern District of Illinois
April 23, 2010
On April 23, 2010, the United States District Court for the Northern District of Illinois found in favor of our client Hospira, Inc. and Abbott Laboratories on all counts of an ERISA class-action lawsuit filed against both companies in 2004. In the lawsuit, representatives of an 8,000-employee class claimed that Hospira and Abbott intended to interfere with their retirement benefits through Abbott's spin-off of its Hospital Products Division, which established Hospira as an independent company, and the implementation of a two-year reciprocal no-hire policy. The suit, in which the plaintiff class sought over $300 million in lost employee benefits, was tried over a period of three weeks in 2009.
In a 97-page opinion, the Court found that neither Hospira nor Abbott violated ERISA in connection with the spin off or the no-hire policy. Of critical importance to the Court's decision was the testimony of the defendants' witnesses, including Hospira's CEO and COO, which the Court found was "highly credible, internally consistent, and amply corroborated by the unquestionably authentic documentary evidence." In ruling in favor of the defendants, the Court also vindicated Abbott's and Hospira's strategic decisionmaking and human resource policies relating to the spin off. The Court explained that "Hospira has been a successful, profitable enterprise in the years since the spin, no doubt in large part because it retained the talent it had at the time it became independent of Abbott."